Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Cannabidiol Oral Solution for the Treatment of Subjects With Prader-Willi Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02844933
Recruitment Status : Terminated (Insys Therapeutics filed Chapter 11 and terminated all studies.)
First Posted : July 26, 2016
Last Update Posted : November 13, 2020
Information provided by (Responsible Party):
Benuvia Therapeutics Inc.

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : June 10, 2019
Actual Study Completion Date : June 10, 2019